Most people taking Trulicity lose between 7 and 11 pounds over the course of a year, depending on the dose. At the standard 1.5 mg dose, clinical trials showed an average loss of about 7.8 pounds at 52 weeks. Higher doses produced more: roughly 9.5 pounds at the 3.0 mg dose and 11.1 pounds at the 4.5 mg dose.
These numbers come from trials in people with type 2 diabetes, and it’s worth understanding what they mean in context. Trulicity is not approved as a weight loss medication. It’s prescribed to lower blood sugar and reduce cardiovascular risk in adults with type 2 diabetes. Weight loss is a secondary benefit, not the primary goal.
Weight Loss by Dose
Trulicity comes in four doses: 0.75 mg, 1.5 mg, 3.0 mg, and 4.5 mg, all given as a once-weekly injection. The pattern is straightforward: higher doses produce more weight loss.
At 36 weeks, the results from the AWARD-11 clinical trial break down like this:
- 1.5 mg: 6.6 pounds lost
- 3.0 mg: 8.4 pounds lost
- 4.5 mg: 10.1 pounds lost
Weight continued to drop through week 52, reaching 7.8 pounds, 9.5 pounds, and 11.1 pounds for those three doses respectively. The losses at the two higher doses were statistically significant compared to the 1.5 mg dose, meaning the difference wasn’t due to chance. Most people start at a lower dose and titrate up over several weeks, so the early months of treatment may show less change than what the 36- and 52-week numbers reflect.
When the Weight Loss Happens
Weight tends to drop steadily over the first 36 weeks and then continues at a slower pace through week 52. You won’t see dramatic results in the first few weeks, partly because most prescribers start you on the lowest dose to minimize side effects before increasing it. The bulk of the measurable change in trials occurred during the first nine months, with a smaller additional reduction between months nine and twelve.
This is a gradual process. If you’re expecting the kind of rapid, significant loss associated with newer weight loss drugs, the timeline and total amount will likely feel modest. Trulicity works on the same class of receptors as those medications, but at different potencies and doses calibrated for blood sugar control rather than maximum weight reduction.
How Trulicity Compares to Ozempic
Ozempic (semaglutide) produces roughly twice the weight loss of Trulicity at comparable doses. In a head-to-head trial, patients on Ozempic’s 0.5 mg dose lost about 10.1 pounds compared to 5.1 pounds with Trulicity’s 0.75 mg dose. At the higher comparison, Ozempic 1 mg led to about 14.3 pounds of loss versus 6.6 pounds with Trulicity 1.5 mg. Both differences were statistically significant.
This gap is one reason Ozempic and its higher-dose sibling Wegovy have gotten more attention for weight management. Both drugs are GLP-1 receptor agonists, but semaglutide appears to have a stronger effect on appetite and body weight at its approved doses. For someone whose primary concern is weight loss rather than blood sugar, this comparison matters. For someone already well-controlled on Trulicity with good tolerability, switching may or may not make sense depending on individual circumstances.
Why Trulicity Causes Weight Loss
Trulicity mimics a gut hormone called GLP-1 that your body releases after eating. This hormone slows stomach emptying, which means food sits in your stomach longer and you feel full sooner. It also acts on appetite centers in the brain to reduce hunger. The combined effect is that people naturally eat less without consciously restricting calories.
The weight loss is not primarily caused by the digestive side effects, though those are common. Nausea affects about 12% to 21% of people depending on the dose, diarrhea occurs in 9% to 13%, and vomiting in 6% to 13%. These symptoms are most common when starting the medication or increasing the dose and typically improve over time. A small percentage of patients, around 1% to 4%, stop taking Trulicity because of gastrointestinal issues.
Not an Approved Weight Loss Drug
Trulicity is FDA-approved for two things: improving blood sugar control in type 2 diabetes and reducing cardiovascular risk in diabetic patients with heart disease or multiple risk factors. It is not approved for weight management in people without diabetes.
The FDA has approved several GLP-1 drugs specifically for obesity treatment, including liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound). These medications are dosed differently and studied in populations with obesity rather than just diabetes. Current American Diabetes Association guidelines recommend GLP-1 receptor agonists as preferred medications for people who have both type 2 diabetes and obesity, but they distinguish between drugs approved for diabetes and those approved for weight loss. Trulicity falls in the diabetes category only.
This means your insurance is unlikely to cover Trulicity if it’s prescribed purely for weight loss without a type 2 diabetes diagnosis. It also means the weight loss data comes from diabetes trials where participants were also managing blood sugar, not from dedicated obesity studies designed to maximize weight reduction.
What Affects Your Results
The 7 to 11 pound range represents an average, and individual results vary considerably. Several factors influence how much weight you lose on Trulicity. Your starting weight matters: people with more weight to lose often see larger absolute drops. Diet and exercise habits play a role, as Trulicity is approved as an add-on to lifestyle changes, not a replacement for them. The dose you reach and how long you stay on it also matter, since higher doses and longer treatment both correlate with greater loss.
Some people lose significantly more than the average, while others lose little or nothing. A portion of patients in clinical trials even gained weight. If weight loss is your primary treatment goal and Trulicity isn’t delivering meaningful results after several months at a therapeutic dose, that’s a conversation worth having with your prescriber about whether a different medication might be more effective.